Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine 0.5% for Pain After Vaginal Hysterectomy
NCT00768456Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Oct 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Postoperative pain at 32 hours. Started Oct 2008; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00768456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768456.